To: Merritt who wrote (868 ) 9/12/1999 11:00:00 AM From: chalu2 Read Replies (1) | Respond to
OT:All I said was that I heard that IMCL was successful in its pancreatic "tests." You then decided that I didn't know that the tests I was referring to were pre-clinical trials. What's your basis for that? Take a look at the IMCL thread. Post #971 by a poster named JEB (who I don't know from a hole in the wall) also expresses the belief that the pancreatic tests went well. Had I said Phase I, II, or III, then you could accuse me of being ignorant. But is all in your confused mind that by using the word "tests", I meant something other than pre-clinicals. In fact, I had forgotten that the test success I mentioned offhand was actually presented to the American Academy of Cancer Research back in April, and that C225 had in two pre-clinicals demonstrated anti-tumor activity in animal models of human pancreatic carcinoma. I don't know what is wrong with you.gao seng's post a while back mentioning another anti-cancer stock, and pointing out an article which questions the mechanism by which angiogenesis occurs. If you'll check, you'll see that I've not mentioned IMCL on these threads until recently, except for maybe one or two questions posted to the IMCL board. Frankly, had I "touted" IMCL to you 8-9 months ago, you'd be sitting on a handsome return.
